Procter & Gamble Company (PG) - Net Assets
Based on the latest financial reports, Procter & Gamble Company (PG) has net assets worth $53.32 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($127.29 Billion) and total liabilities ($73.97 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Procter & Gamble Company (PG) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $53.32 Billion |
| % of Total Assets | 41.89% |
| Annual Growth Rate | 5.85% |
| 5-Year Change | 12.07% |
| 10-Year Change | -9.83% |
| Growth Volatility | 39.12 |
Procter & Gamble Company - Net Assets Trend (1986–2025)
This chart illustrates how Procter & Gamble Company's net assets have evolved over time, based on quarterly financial data. Also explore PG total asset value for the complete picture of this company's asset base.
Annual Net Assets for Procter & Gamble Company (1986–2025)
The table below shows the annual net assets of Procter & Gamble Company from 1986 to 2025. For live valuation and market cap data, see Procter & Gamble Company market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $52.28 Billion | +3.41% |
| 2024-06-30 | $50.56 Billion | +7.42% |
| 2023-06-30 | $47.06 Billion | +0.45% |
| 2022-06-30 | $46.85 Billion | +0.43% |
| 2021-06-30 | $46.65 Billion | -0.48% |
| 2020-06-30 | $46.88 Billion | -1.47% |
| 2019-06-30 | $47.58 Billion | -10.03% |
| 2018-06-30 | $52.88 Billion | -5.19% |
| 2017-06-30 | $55.78 Billion | -3.80% |
| 2016-06-30 | $57.98 Billion | -8.04% |
| 2015-06-30 | $63.05 Billion | -9.90% |
| 2014-06-30 | $69.98 Billion | +1.84% |
| 2013-06-30 | $68.71 Billion | +7.30% |
| 2012-06-30 | $64.03 Billion | -5.83% |
| 2011-06-30 | $68.00 Billion | +10.68% |
| 2010-06-30 | $61.44 Billion | -3.07% |
| 2009-06-30 | $63.38 Billion | -8.80% |
| 2008-06-30 | $69.49 Billion | +4.10% |
| 2007-06-30 | $66.76 Billion | +6.12% |
| 2006-06-30 | $62.91 Billion | +240.50% |
| 2005-06-30 | $18.48 Billion | +6.93% |
| 2004-06-30 | $17.28 Billion | +6.75% |
| 2003-06-30 | $16.19 Billion | +18.09% |
| 2002-06-30 | $13.71 Billion | +14.12% |
| 2001-06-30 | $12.01 Billion | -2.25% |
| 2000-06-30 | $12.29 Billion | +1.90% |
| 1999-06-30 | $12.06 Billion | -1.45% |
| 1998-06-30 | $12.24 Billion | +1.58% |
| 1997-06-30 | $12.05 Billion | +2.76% |
| 1996-06-30 | $11.72 Billion | +10.70% |
| 1995-06-30 | $10.59 Billion | +19.89% |
| 1994-06-30 | $8.83 Billion | +18.69% |
| 1993-06-30 | $7.44 Billion | -17.97% |
| 1992-06-30 | $9.07 Billion | +17.26% |
| 1991-06-30 | $7.74 Billion | +2.90% |
| 1990-06-30 | $7.52 Billion | +44.16% |
| 1989-06-30 | $5.21 Billion | -17.71% |
| 1988-06-30 | $6.34 Billion | +10.40% |
| 1987-06-30 | $5.74 Billion | +0.63% |
| 1986-06-30 | $5.70 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Procter & Gamble Company's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2343.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $129.97 Billion | 249.89% |
| Common Stock | $4.01 Billion | 7.71% |
| Other Comprehensive Income | $-12.14 Billion | -23.35% |
| Total Equity | $52.01 Billion | 100.00% |
Procter & Gamble Company Competitors by Market Cap
The table below lists competitors of Procter & Gamble Company ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bank of America Corp
NYSE:BAC
|
$349.79 Billion |
|
Caterpillar Inc
NYSE:CAT
|
$362.70 Billion |
|
Berkshire Hathaway Inc
NYSE:BRK-A
|
$363.55 Billion |
|
AbbVie Inc
NYSE:ABBV
|
$365.30 Billion |
|
Palantir Technologies Inc.
NASDAQ:PLTR
|
$330.13 Billion |
|
Palantir Technologies Inc. Class A Common Stock
NYSE:PLTR
|
$324.25 Billion |
|
Agricultural Bank of China Ltd Class A
SHG:601288
|
$323.27 Billion |
|
The Home Depot Inc
NYSE:HD
|
$322.43 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Procter & Gamble Company's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 50,286,000,000 to 52,012,000,000, a change of 1,726,000,000 (3.4%).
- Net income of 15,974,000,000 contributed positively to equity growth.
- Dividend payments of 9,872,000,000 reduced retained earnings.
- Share repurchases of 6,500,000,000 reduced equity.
- Other comprehensive income decreased equity by 243,000,000.
- Other factors increased equity by 2,367,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $15.97 Billion | +30.71% |
| Dividends Paid | $9.87 Billion | -18.98% |
| Share Repurchases | $6.50 Billion | -12.5% |
| Other Comprehensive Income | $-243.00 Million | -0.47% |
| Other Changes | $2.37 Billion | +4.55% |
| Total Change | $- | 3.43% |
Book Value vs Market Value Analysis
This analysis compares Procter & Gamble Company's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.95x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 68.59x to 6.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-06-30 | $2.15 | $147.26 | x |
| 1987-06-30 | $2.18 | $147.26 | x |
| 1988-06-30 | $2.33 | $147.26 | x |
| 1989-06-30 | $1.91 | $147.26 | x |
| 1990-06-30 | $2.59 | $147.26 | x |
| 1991-06-30 | $2.65 | $147.26 | x |
| 1992-06-30 | $3.14 | $147.26 | x |
| 1993-06-30 | $2.70 | $147.26 | x |
| 1994-06-30 | $3.04 | $147.26 | x |
| 1995-06-30 | $3.54 | $147.26 | x |
| 1996-06-30 | $3.90 | $147.26 | x |
| 1997-06-30 | $4.00 | $147.26 | x |
| 1998-06-30 | $3.93 | $147.26 | x |
| 1999-06-30 | $4.17 | $147.26 | x |
| 2000-06-30 | $4.30 | $147.26 | x |
| 2001-06-30 | $4.27 | $147.26 | x |
| 2002-06-30 | $4.88 | $147.26 | x |
| 2003-06-30 | $5.78 | $147.26 | x |
| 2004-06-30 | $6.19 | $147.26 | x |
| 2005-06-30 | $6.75 | $147.26 | x |
| 2006-06-30 | $19.14 | $147.26 | x |
| 2007-06-30 | $19.64 | $147.26 | x |
| 2008-06-30 | $20.95 | $147.26 | x |
| 2009-06-30 | $20.01 | $147.26 | x |
| 2010-06-30 | $19.72 | $147.26 | x |
| 2011-06-30 | $22.53 | $147.26 | x |
| 2012-06-30 | $21.57 | $147.26 | x |
| 2013-06-30 | $23.23 | $147.26 | x |
| 2014-06-30 | $23.83 | $147.26 | x |
| 2015-06-30 | $21.65 | $147.26 | x |
| 2016-06-30 | $20.16 | $147.26 | x |
| 2017-06-30 | $20.14 | $147.26 | x |
| 2018-06-30 | $19.68 | $147.26 | x |
| 2019-06-30 | $18.58 | $147.26 | x |
| 2020-06-30 | $17.72 | $147.26 | x |
| 2021-06-30 | $17.83 | $147.26 | x |
| 2022-06-30 | $18.35 | $147.26 | x |
| 2023-06-30 | $18.83 | $147.26 | x |
| 2024-06-30 | $20.34 | $147.26 | x |
| 2025-06-30 | $21.19 | $147.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Procter & Gamble Company utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 30.71%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.95%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 2.41x
- Recent ROE (30.71%) is above the historical average (22.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | 12.43% | 4.59% | 1.18x | 2.29x | $138.60 Million |
| 1987 | 5.70% | 1.92% | 1.24x | 2.39x | $-247.00 Million |
| 1988 | 16.10% | 5.28% | 1.30x | 2.34x | $386.30 Million |
| 1989 | 23.13% | 5.64% | 1.31x | 3.14x | $684.50 Million |
| 1990 | 21.31% | 6.65% | 1.30x | 2.46x | $850.20 Million |
| 1991 | 22.92% | 6.56% | 1.32x | 2.65x | $999.40 Million |
| 1992 | 20.64% | 6.38% | 1.22x | 2.65x | $964.90 Million |
| 1993 | -8.82% | -2.16% | 1.22x | 3.35x | $-1.40 Billion |
| 1994 | 25.03% | 7.30% | 1.19x | 2.89x | $1.33 Billion |
| 1995 | 24.98% | 7.90% | 1.19x | 2.66x | $1.59 Billion |
| 1996 | 25.99% | 8.63% | 1.27x | 2.37x | $1.87 Billion |
| 1997 | 28.35% | 9.55% | 1.30x | 2.29x | $2.21 Billion |
| 1998 | 30.89% | 10.17% | 1.20x | 2.53x | $2.56 Billion |
| 1999 | 31.21% | 9.87% | 1.19x | 2.66x | $2.56 Billion |
| 2000 | 28.83% | 8.87% | 1.17x | 2.78x | $2.31 Billion |
| 2001 | 24.33% | 7.45% | 1.14x | 2.86x | $1.72 Billion |
| 2002 | 31.75% | 10.82% | 0.99x | 2.98x | $2.98 Billion |
| 2003 | 32.04% | 11.96% | 0.99x | 2.70x | $3.57 Billion |
| 2004 | 35.63% | 11.98% | 0.90x | 3.30x | $4.43 Billion |
| 2005 | 37.47% | 12.20% | 0.92x | 3.33x | $5.08 Billion |
| 2006 | 13.80% | 12.73% | 0.50x | 2.16x | $2.39 Billion |
| 2007 | 15.49% | 13.52% | 0.55x | 2.07x | $3.66 Billion |
| 2008 | 17.38% | 14.77% | 0.57x | 2.07x | $5.13 Billion |
| 2009 | 18.11% | 14.90% | 0.57x | 2.14x | $5.12 Billion |
| 2010 | 20.84% | 16.42% | 0.61x | 2.10x | $6.62 Billion |
| 2011 | 17.44% | 14.55% | 0.59x | 2.05x | $5.03 Billion |
| 2012 | 16.95% | 13.12% | 0.62x | 2.08x | $4.41 Billion |
| 2013 | 16.62% | 14.12% | 0.58x | 2.05x | $4.51 Billion |
| 2014 | 16.82% | 15.65% | 0.52x | 2.08x | $4.72 Billion |
| 2015 | 11.27% | 9.95% | 0.55x | 2.07x | $794.10 Million |
| 2016 | 18.33% | 16.09% | 0.51x | 2.22x | $4.77 Billion |
| 2017 | 27.77% | 23.56% | 0.54x | 2.18x | $9.81 Billion |
| 2018 | 18.64% | 14.59% | 0.56x | 2.26x | $4.52 Billion |
| 2019 | 8.26% | 5.76% | 0.59x | 2.44x | $-822.40 Million |
| 2020 | 28.00% | 18.36% | 0.59x | 2.59x | $8.37 Billion |
| 2021 | 30.85% | 18.79% | 0.64x | 2.57x | $9.67 Billion |
| 2022 | 31.64% | 18.38% | 0.68x | 2.52x | $10.08 Billion |
| 2023 | 31.33% | 17.87% | 0.68x | 2.58x | $9.98 Billion |
| 2024 | 29.59% | 17.70% | 0.69x | 2.43x | $9.85 Billion |
| 2025 | 30.71% | 18.95% | 0.67x | 2.41x | $10.77 Billion |
Industry Comparison
This section compares Procter & Gamble Company's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,363,927,605
- Average return on equity (ROE) among peers: -469.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Procter & Gamble Company (PG) | $53.32 Billion | 12.43% | 1.39x | $344.11 Billion |
| Acme United Corporation (ACU) | $6.50 Million | -49.23% | 3.20x | $159.26 Million |
| Bruush Oral Care Inc. (BRSHF) | $163.14K | -5449.60% | 11.70x | $10.10K |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $150.28K | 127.30% | 15.76x | $12.69 Million |
| Church & Dwight Company Inc (CHD) | $2.04 Billion | 15.17% | 0.53x | $22.73 Billion |
| Colgate-Palmolive Company (CL) | $243.00 Million | 832.92% | 51.16x | $70.34 Billion |
| The Clorox Company (CLX) | $297.00 Million | 218.18% | 14.21x | $10.53 Billion |
| Coty Inc (COTY) | $9.87 Billion | -4.28% | 1.28x | $1.95 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-37.79 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $453.17K | -417.72% | 4.36x | $19.52 Million |
| Estee Lauder Companies Inc (EL) | $1.22 Billion | 36.81% | 2.38x | $19.60 Billion |
About Procter & Gamble Company
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing produc… Read more